Based on the notion of “transcriptional addiction,” targeting transcription regulators, including CDK7, has emerged as a powerful strategy to attenuate cancer dependency, particularly in cancers that rely on SE-driven genes (e.g., MYC, RUNX2, SOX2, SOX9). The gene discussed is SOX2; the disease is cancer.